Screener

Eligibility screening

Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer

Sponsored by Janssen Research & Development, LLCStudy detailsClinicalTrials.gov

3 US sites in FL, NY, OH

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.